English | Español

Technology/Innovation
+ Technology/Innovation
Amanda Rupp | Mar 11, 2016

VBI Vaccines releases new data from cancer immunotherapy program
+ Technology/Innovation
Jeff Gantt | Mar 11, 2016

Victoza shows positive results in LEADER trial
+ Technology/Innovation
Amanda Rupp | Mar 11, 2016

Amgen submits supplemental Biologics License Application for Blincyto treatment
+ Technology/Innovation
Amanda Rupp | Mar 11, 2016

ALS Association invests in new proposals for ALS treatment developments
+ Technology/Innovation
Jamie Barrand | Mar 11, 2016

Opdivo under consideration in Europe for new indications
+ Technology/Innovation
Jeff Gantt | Mar 10, 2016

TiGenix’s Cx601 trial shows positive results
+ Regulatory
Vimbai Chikomo | Mar 10, 2016

HHS estimates 43,000 have lost Obamacare tax credit after failing to file 2014 returns
+ Regulatory
Kerry Goff | Mar 10, 2016

Aetna says Hep C coverage likely to expand with new research

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation